
Opinion|Videos|June 26, 2024
Payer Coverage Considerations for New Treatments for Alzheimer Disease
Experts discuss how payers can prepare for new treatments and plan adequate coverage for patients with Alzheimer disease.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- How can plan sponsors effectively prepare for these new treatments and plan coverage in a way that ensure adequate care for patients with Alzheimer disease and availability of coverage for all patients?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
3
Experts, Patients Highlight Barriers to Arthritis Care Amid World Arthritis Day Observance
4
Medical School Diversity Declines Following Affirmative Action Repeal
5